Lu Peifen, Yu Zenong, Wang Kangning, Zhai Yongping, Chen Bing, Liu Ming, Xu Peipei, Li Feng, Zhao Quan
The State Key Laboratory of Pharmaceutical Biotechnology, Department of Hematology, the Affiliated Drum Tower Hospital of Nanjing University Medical School, China-Australia Institute of Translational Medicine, School of Life Sciences, Nanjing University, Nanjing, China.
Department of Hematology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.
J Cancer. 2022 Feb 28;13(5):1530-1539. doi: 10.7150/jca.69216. eCollection 2022.
DEAD-box RNA helicase 21 (DDX21), is a nucleolar protein harboring ATP-dependent double-stranded RNA unwinding activities, essential in rRNA processing and ribosome biogenesis. However, its role in colorectal cancer (CRC) progression remains unclear. In this study, we show that knockdown of DDX21 significantly inhibited CRC cell proliferation and blocked cell cycle at the G2/M phase. Gene profile analysis and ChIP assays revealed that DDX21 activated CDK1 gene expression through binding to the gene promoter. In addition, we found that DDX21 directly recruited WDR5 to enhance trimethylation of histone H3 on Lys 4 (H3K4me3) on the CDK1 promoter. Importantly, elevated expression of DDX21 in CRC patients was positively correlated with expression of CDK1, and these CRC patients had shorter overall survival. These findings reveal a critical novel role of DDX21 in transcriptional and epigenetic control of CRC cell proliferation. Taken together, this study uncovers that DDX21 interacted with WDR5 to promote colorectal cancer cell proliferation by activating CDK1 expression, suggesting that targeting DDX21 may be an alternative new strategy for CRC treatment.
DEAD盒RNA解旋酶21(DDX21)是一种核仁蛋白,具有ATP依赖性双链RNA解旋活性,在rRNA加工和核糖体生物合成中至关重要。然而,其在结直肠癌(CRC)进展中的作用仍不清楚。在本研究中,我们发现敲低DDX21可显著抑制CRC细胞增殖,并将细胞周期阻滞在G2/M期。基因谱分析和染色质免疫沉淀试验表明,DDX21通过与基因启动子结合激活CDK1基因表达。此外,我们发现DDX21直接招募WDR5以增强CDK1启动子上组蛋白H3第4位赖氨酸的三甲基化(H3K4me3)。重要的是,CRC患者中DDX21的高表达与CDK1的表达呈正相关,且这些CRC患者的总生存期较短。这些发现揭示了DDX21在CRC细胞增殖的转录和表观遗传调控中的关键新作用。综上所述,本研究发现DDX21与WDR5相互作用,通过激活CDK1表达促进结直肠癌细胞增殖,提示靶向DDX21可能是CRC治疗的一种新的替代策略。